CURE Magazine Seeks Nominations for 2018 MPN Heroes

The award recognizes individuals and organizations who are making a difference in the myeloproliferative neoplasm community
PUBLISHED June 28, 2018
CRANBURY, N.J.--(BUSINESS WIRE)--CURE® magazine, the nation’s leading digital and print media enterprise focused on patients with cancer, cancer centers and advocacy groups, is accepting nominations for the 2018 MPN Heroes® awards. This program honors individuals and organizations who have made a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within the MPN community or a commitment to individual patients.

“We are excited to be accepting nominations for this year’s MPN Heroes Recognition Program. We are proud to recognize another group of exceptional individuals who each and every day make a difference within the MPN community,” said Michael J. Hennessy Jr, president of MJH Associates, parent company of CURE®.

Nominations are accepted from the community at large. A panel of judges will review the nominations and pick the finalists and winners in two categories: Commitment to the Individual and Commitment to the Broader MPN Community. For more information, to submit a nomination and to learn more about this year’s rules and judges, visit mpnheroes.com.

This year’s winners will be honored at the sixth annual MPN Heroes Celebration Event on November 30 at the Hard Rock in San Diego.

The MPN Heroes Recognition Program is sponsored by Incyte Corporation and CURE Media Group, publishers of CURE® magazine. Incyte partners with CURE Media Group to support the program, with CURE hosting the annual MPN Heroes Celebration Event recognizing heroes of the MPN community. Supporting the MPN community is an ongoing effort of Incyte, a global biopharmaceutical company that discovers and develops novel medicines to meet serious unmet medical needs in oncology and other diseases. Individuals or entities supported through funding or directed by Incyte are not eligible for consideration or recognition.

About CURE®

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates Inc. family of businesses, which includes the acclaimed OncLive® (onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or mjhassoc.com. CURE Connections and CURE are registered trademarks of CURE Media Group, LLC.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information, please visit the company’s website at incyte.com.

Follow @Incyte on Twitter at twitter.com/Incyte.
MPN Heroes is a registered trademark of Incyte.
Contacts
CURE® Media
Theresa Burek, 609-325-4811
Tburek@mjhassoc.com
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the MPN CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In